Evidence map›Paper›PMID 26942285›Full record

ArticleAmerican journal of human genetics2016

A Locus at 5q33.3 Confers Resistance to Tuberculosis in Highly Susceptible Individuals.

Rafal S Sobota, Catherine M Stein, Nuri Kodaman, Laura B Scheinfeldt, Isaac Maro, Wendy Wieland-Alter, Robert P Igo, Albert Magohe, LaShaunda L Malone, Keith Chervenak and 15 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Offense and Defense in Granulomatous Inflammation Disease.Frontiers in cellular and infection microbiology · 2022
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Genetics and evolution of tuberculosis pathogenesis: New perspectives and approaches.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2020
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 12 institutions in 7 countries.

Rafal S SobotaVanderbilt Genetics Institute, Vanderbilt University, Nashville, TN 37232, USA; Geisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA.
Catherine M SteinDepartment of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH 44106, USA; Tuberculosis Research Unit, Case Western Reserve University, Cleveland, OH 44106, USA.
Nuri KodamanVanderbilt Genetics Institute, Vanderbilt University, Nashville, TN 37232, USA; Geisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA; Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH 44106, USA.
Laura B ScheinfeldtDepartment of Genetics, University of Pennsylvania, Philadelphia, PA 19104, USA; Coriell Institute for Medical Research, Camden, NJ 08103, USA.
Isaac MaroTokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.
Wendy Wieland-AlterGeisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA.
Robert P IgoDepartment of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH 44106, USA.
Albert MagoheMuhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
LaShaunda L MaloneTuberculosis Research Unit, Case Western Reserve University, Cleveland, OH 44106, USA.
Keith ChervenakTuberculosis Research Unit, Case Western Reserve University, Cleveland, OH 44106, USA.
Noemi B HallDepartment of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH 44106, USA.
Chawangwa ModongoDivision of Infectious Diseases, University of Pennsylvania, Philadelphia, PA 19104, USA; Botswana-UPenn Partnership, 214 Independence Avenue, Gaborone, Botswana; Department of Medicine, University of Botswana, Gaborone, Botswana.
Nicola ZetolaDivision of Infectious Diseases, University of Pennsylvania, Philadelphia, PA 19104, USA; Botswana-UPenn Partnership, 214 Independence Avenue, Gaborone, Botswana; Department of Medicine, University of Botswana, Gaborone, Botswana.
Mecky MateeMuhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Moses JolobaUganda-CWRU Research Collaboration, Kampala, Uganda; College of Health Sciences Makerere University and Mulago Hospital, Kampala, Uganda.
Alain FromentUMR 208, Institut de Recherche pour le Développement and Musée de l'Homme, Muséum National d'Histoire Naturelle, 75116 Paris, France.
Thomas B NyamboDepartment of Biochemistry, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Jason H MooreGeisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
William K ScottJohn P. Hussman Institute for Human Genomics, University of Miami, Miami, FL 33136, USA.
Timothy LaheyGeisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA.
W Henry BoomTuberculosis Research Unit, Case Western Reserve University, Cleveland, OH 44106, USA; Uganda-CWRU Research Collaboration, Kampala, Uganda.
C Fordham von ReynGeisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA.
Sarah A TishkoffDepartment of Genetics, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Giorgio SirugoCentro di Ricerca, Ospedale San Pietro Fatebenefratelli, 00189 Rome, Italy.
Scott M WilliamsGeisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA; Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH 44106, USA. Electronic address: smw154@case.edu.
Case Western Reserve University · USDartmouth College · USMuhimbili University of Health and Allied Sciences · TZUniversity of Pennsylvania · USVanderbilt University · USBotswana Open University · BWCoriell Institute For Medical Research · USMakerere University · UGMusée de l'Homme · FROspedale San Pietro Fatebenefratelli · ITTokyo Medical and Dental University · JPUniversity of Miami · US

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ROBERT GROSS · 1999 to 2026
$78.6M
WG3: HIV, Co-infections and Co-morbiditiesP30AI036219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI Sharon L. Hillier, JONATHAN KARN · 1994 to 2026
$50.0M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
Quantitative Biology Research InstituteP20GM103534 · NIGMS · DARTMOUTH COLLEGE · PI AMOS, CHRISTOPHER I. · 2012 to 2016
$8.6M
BIOMETRIC-GENETIC ANALYSIS OF CARDIOVASCULAR DISEASET32HL007567 · NHLBI · LOUISIANA STATE UNIV HSC NEW ORLEANS · PI ZHU, XIAOFENG · 1985 to 2021
$6.0M
Tuberculosis Prevention Research Unit /TBRU/-266095383N01AI095383 · NIAID · CASE WESTERN RESERVE UNIVERSITY · 2000 to 2005
$5.6M
Bioinformatics Strategies for Genome-Wide Association StudiesR01LM010098 · NLM · UNIVERSITY OF PENNSYLVANIA · PI MOORE, JASON H., WILLIAMS, SCOTT MATTHEW · 2009 to 2023
$5.1M
Bioinformatics Strategies: Biodefense Vaccine ResearchR01AI059694 · NIAID · DARTMOUTH COLLEGE · PI MOORE, JASON H. · 2004 to 2012
$4.5M
Machine Learning Prediction of Cancer SusceptibilityR01LM009012 · NLM · UNIVERSITY OF PENNSYLVANIA · PI MOORE, JASON H. · 2006 to 2014
$3.3M
Biomedical Computing and Informatics Strategies for Infectious Disease ResearchR01AI116794 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI MOORE, JASON H. · 2016 to 2020
$2.9M
Integrative Genomics of Body Size and Metabolism in Ethnically Diverse AfricansR01GM113657 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI TISHKOFF, SARAH ANNE · 2015 to 2019
$2.8M
Integrative Genomic Analyses of Human Evolution and Adaptation in AfricaR35GM134957 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI TISHKOFF, SARAH ANNE · 2020 to 2024
$2.7M
NCCDPHP CDC HHS 8DP1ES022577-04NHLBI NIH HHS R01 HL096811NHLBI NIH HHS R01HL096811NHLBI NIH HHS R01HL10566113NHLBI NIH HHS T32 HL007567NHLBI NIH HHS T32HL007567NIAID NIH HHS AI116794NIAID NIH HHS AI59694NIAID NIH HHS HHSN266200700022C/N01-AI70022NIAID NIH HHS N01 AI070022NIAID NIH HHS N01 AI095383NIAID NIH HHS N01-AI95383NIAID NIH HHS P30 AI036219NIAID NIH HHS P30 AI045008NIAID NIH HHS R01 AI059694NIAID NIH HHS R01 AI116794NIDDK NIH HHS R01 DK104339NIEHS NIH HHS DP1 ES022577NIGMS NIH HHS 1R01GM113657-01NIGMS NIH HHS P20 GM103534NIGMS NIH HHS R01 GM113657NIGMS NIH HHS R35 GM134957NIGMS NIH HHS T32 GM007347NIGMS NIH HHS T32 GM07347NLM NIH HHS LM009012NLM NIH HHS LM010098NLM NIH HHS R01 LM009012NLM NIH HHS R01 LM010098
6 · The paper itself

Abstract

Immunosuppression resulting from HIV infection increases the risk of progression to active tuberculosis (TB) both in individuals newly exposed to Mycobacterium tuberculosis (MTB) and in those with latent infections. We hypothesized that HIV-positive individuals who do not develop TB, despite living in areas where it is hyperendemic, provide a model of natural resistance. We performed a genome-wide association study of TB resistance by using 581 HIV-positive Ugandans and Tanzanians enrolled in prospective cohort studies of TB; 267 of these individuals developed active TB, and 314 did not. A common variant, rs4921437 at 5q33.3, was significantly associated with TB (odds ratio = 0.37, p = 2.11 × 10(-8)). This variant lies within a genomic region that includes IL12B and is embedded in an H3K27Ac histone mark. The locus also displays consistent patterns of linkage disequilibrium across African populations and has signals of strong selection in populations from equatorial Africa. Along with prior studies demonstrating that therapy with IL-12 (the cytokine encoded in part by IL12B, associated with longer survival following MTB infection in mice deficient in CD4 T cells), our results suggest that this pathway might be an excellent target for the development of new modalities for treating TB, especially for HIV-positive individuals. Our results also indicate that studying extreme disease resistance in the face of extensive exposure can increase the power to detect associations in complex infectious disease.

Indexed as

Genetic LociGenetic Predisposition to DiseaseAdolescentFemaleGene FrequencyGenome-Wide Association StudyHIV InfectionsHumansInterleukin-12 Subunit p40Linkage DisequilibriumLogistic ModelsMaleMycobacterium tuberculosisProspective StudiesRisk FactorsTanzaniaIL12B protein, humanInterleukin-12 Subunit p40East Africahistone acetylationHIVIL12BselectionUBLCP1

Identifiers

PMID26942285
PMCPMC4800052
OpenAlexW2290945089

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.